Detalhe da pesquisa
1.
Randomized comparison between KTd and KRd induction therapy followed by maintenance therapy with K or observation in transplant-ineligible patients with newly diagnosed multiple myeloma.
Am J Hematol
; 99(5): 1008-1011, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38425185
2.
Hepatic brucellosis detected by 18F-FDG PET/CT.
Hell J Nucl Med
; 25(3): 312-314, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36507886
3.
Landscape of HER2-low metastatic breast cancer (MBC): results from the Austrian AGMT_MBC-Registry.
Breast Cancer Res
; 23(1): 112, 2021 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34906198
4.
The McCAVE Trial: Vanucizumab plus mFOLFOX-6 Versus Bevacizumab plus mFOLFOX-6 in Patients with Previously Untreated Metastatic Colorectal Carcinoma (mCRC).
Oncologist
; 25(3): e451-e459, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32162804
5.
Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemia.
Haematologica
; 104(10): 2053-2060, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31097627
6.
Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group.
Int J Mol Sci
; 18(2)2017 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28212292
7.
LM02 trial Perioperative treatment with panitumumab and FOLFIRI in patients with wild-type RAS, potentially resectable colorectal cancer liver metastases-a phase II study.
Front Oncol
; 13: 1231600, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37621684
8.
Successful alemtuzumab retreatment in progressive B-cell chronic lymphocytic leukemia: a multicenter survey in 30 patients.
Ann Hematol
; 90(9): 1083-91, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21350830
9.
Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: results of a phase II trial (AGMT MBC-6).
Ther Adv Med Oncol
; 13: 17588359211042301, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34691243
10.
Postoperative chemoradiotherapy with cisplatin is superior to radioimmunotherapy with cetuximab and radiotherapy alone : Analysis of the Austrian head and neck cancer registry of the AGMT.
Wien Klin Wochenschr
; 133(21-22): 1131-1136, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34528125
11.
Comparison of nab-paclitaxel plus gemcitabine in elderly versus younger patients with metastatic pancreatic cancer: Analysis of a multicentre, prospective, non-interventional study.
Eur J Cancer
; 143: 101-112, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33296830
12.
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset.
Ann Oncol
; 26(4): 822-825, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25814651
13.
REGO-ACT: assessment of physical activity during treatment with regorafenib for metastatic colorectal cancer.
Wien Klin Wochenschr
; 132(15-16): 423-430, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32643016
14.
Local and Central Evaluation of HER2 Positivity and Clinical Outcome in Advanced Gastric and Gastroesophageal Cancer-Results from the AGMT GASTRIC-5 Registry.
J Clin Med
; 9(4)2020 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32235305
15.
The AST/ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine: post hoc analysis of an Austrian multicenter, noninterventional study.
Ther Adv Med Oncol
; 12: 1758835919900872, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32313566
16.
Multicenter phase II study of pegylated liposomal doxorubicin in combination with vinorelbine as first-line treatment in elderly patients with metastatic breast cancer.
Onkologie
; 32(1-2): 18-24, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19209014
17.
Rituximab maintenance overcomes the negative prognostic factor of obesity in CLL: Subgroup analysis of the international randomized AGMT CLL-8a mabtenance trial.
Cancer Med
; 8(4): 1401-1405, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30888118
18.
Cardiotoxicity with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone compared to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone in frontline treatment of patients with diffuse large B-cell lymphoma: A randomised phase-III study from the Austrian Cancer Drug Therapy Working Group [Arbeitsgemeinschaft Medikamentöse Tumortherapie AGMT](NHL-14).
Eur J Cancer
; 58: 112-21, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26990931
19.
Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications.
J Hematol Oncol
; 9: 39, 2016 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-27084507
20.
Rituximab maintenance versus observation alone in patients with chronic lymphocytic leukaemia who respond to first-line or second-line rituximab-containing chemoimmunotherapy: final results of the AGMT CLL-8a Mabtenance randomised trial.
Lancet Haematol
; 3(7): e317-29, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27374465